Febbo William J's Form 4 filing
OptimizeRx Corp (OPRX) · filed Feb 23, 2022
- Accession no.
- 0001213900-22-008987
- Filed
- Feb 23, 2022
- Trade date
- Feb 18, 2022
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market sales total $728.8K. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Febbo William JCIK 0001413987 | Director, Officer (CHIEF EXECUTIVE OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 18, 2022 | Common Stock | SSaleDisposed | −9,200 | $43.38 | −$399,096 | 453,138 | Direct | |
| Feb 18, 2022 | Common Stock | SSaleDisposed | −7,066 | $44.12 | −$311,751.92 | 446,072 | Direct | |
| Feb 18, 2022 | Common Stock | SSaleDisposed | −400 | $44.96 | −$17,984 | 445,672 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.